Statin Use in Metabolic Dysfunction-Associated Steatotic Liver Disease and Effects on Vibration-Controlled Transient Elastography-Derived Scores—A Population-Based Inverse Probability Treatment Weighting Analysis

Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease globally. The impact of statins on liver fibrosis severity in MASLD individuals remains uncertain, despite their known cardiovascular benefits. Methods: A cross-secti...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Natchaya Polpichai, Sakditad Saowapa, Aunchalee Jaroenlapnopparat, Leandro Sierra, Pojsakorn Danpanichkul, Panisara Fangsaard, Phuuwadith Wattanachayakul, Apichat Kaewdech
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2024-12-01
Edice:	Livers
Témata:	Statins MASLD NAFLD MASH NASH liver fibrosis
On-line přístup:	https://www.mdpi.com/2673-4389/4/4/46
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!